The dizzy athlete

Current Sports Medicine Reports

Volumn 6, Issue 1, 2007, Pages 25-31

  Klenck, Chris A ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUDROCORTISONE; FLUOXETINE; HYPERTENSIVE FACTOR; METOPROLOL; MIDODRINE; PAROXETINE; PLACEBO; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE;

ANAMNESIS; ATHLETE; BODY EQUILIBRIUM; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG EFFECT; ELECTROCARDIOGRAM; HEAT INJURY; HUMAN; ORTHOSTATIC HYPOTENSION; PHYSICAL EXAMINATION; PRESYNCOPE; REVIEW; SALT INTAKE; SYNCOPE; VERTIGO;

ATHLETIC INJURIES; DIAGNOSIS, DIFFERENTIAL; DIZZINESS; HUMANS; SPORTS; SYNCOPE; VERTIGO;

EID: 33846989026     PISSN: 1537890X     EISSN: 15378918     Source Type: Journal    
DOI: 10.1007/s11932-007-0008-9     Document Type: Review

References (34)

1. Sloane PD, Coeytaux RR, Beck RS, et al.: Dizziness: state of the science. Ann Intern Med 2001, 134(9 Pt 2):823-832.
2. Ovadia M: Head-upright tilt testing and syncope in athletes. In The Athlete and Heart Disease: Diagnosis, Evaluation, and Management. Edited by Williams RA. Philadelphia: Lippincott Williams & Wilkins; 1999:217-248.
3. Branch WT, Barton J: Approach to the patient with dizziness. UpToDate 2006. Available at http://www.uptodate.con). Accessed November 16, 2006.
4. Oh JH, Hanusa BH, Kapoor WN: Do symptoms predict cardiac arrhythmias and mortality in patients with syncope? Arch Intern Med 1999, 159:375-380.
5. Mathias CJ, Deguchi K, Schatz I: Observations on recurrent syncope and presyncope in 641 patients. Lancet 2001, 357:348-353.
6. Kapoor WN: Syncope. N Engl J Med 2000, 343:1856- 1862.
7. Wisten A, Messner T: Symptoms preceeding sudden cardiac death in the young are common but often misinterpreted. Scand Cardiovasc J 2005, 39:143-149.
8. •• Strickberger SA, Benson DW, Biaggioni I, et al.: AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomie Society. Circulation 2006, 113:316-327. Scientific statement provides detailed explanations for the evaluation of syncope for various patient presentations.
9. Olshansky B. Evaluation of the patient with syncope. UpToDate 2006. Available at http://www.uptodate.com. Accessed November 16, 2006.
10. Kinlay S, Leitch JW, Neil A, et al.: Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. A controlled clinical trial. Ann Intern Med 1996, 124(1 Pt 1):16-20.
11. Sivakumaran S, Krahn AD, Klein GJ, et al.: A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope. Am J Med 2003, 115:1-5.
12. Inamdar V, Mehta S, Juang G, et al.: The utility of implantable loop recorders for diagnosing unexplained syncope in 100 consecutive patients: five-year, single-center experience. J Invasive Cardiol 2006, 18:313-315.
13. Dindar A, Cetin B, Ertugrul T, et al.: Sublingual isosorbide dinitrate-stimulated tilt test for diagnosis of vasovagal syncope in children and adolescents. Pediatr Cardiol 2003, 24:270-273.
14. Lewis DA, Zlotocha J, Henke L, et al.: Specificity of head-up tilt testing in adolescents: effect of various degrees of tilt challenge in normal control subjects. J Am Coll Cardiol 1997, 30:1057-1060.
15. Alehan D, Celiker A, Ozme S: Head-up tilt test: a highly sensitive, specific test for children with unexplained syncope. Pediatr Cardiol 1996, 17:86-90.
16. Kapoor WN: Using a tilt table to evaluate syncope. Am J Med Sci 1999, 317:110-116.
17. Salim MA, Di Sessa TG: Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol 2005, 45:484-488.
18. Kaufmann H, Saadia D, Voustianiouk A: Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol 2002, 52:342-345.
19. Mahanonda N, Bhuripanyo K, Kangkagate C, et al.: Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995, 130:1250-1253.
20. Sheldon R, Connolly S, Rose S, et al.: Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006, 113:1164-1170.
21. Theodorakis GN, Leftheriotis D, Livanis EG, et al.: Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study. Europace 2006, 8:193-198.
22. Di Girolamo E, Di Iorio C, Sabatini P, et al.: Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999, 33:1227-1230.
23. Connolly SJ, Sheldon R, Roberts RS, et al.: The North American Vasovagal Pacemaker Study (VPS): a randomized trial of permanent cardiac pacing for the Prevention of vasovagal syncope. J Am Coll Cardiol 1999, 33:16-20.
24. Raviele A, Giada F, Menozzi C, et al.: A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J 2004, 25:1741-1748.
25. Gajek J, Zysko D, Mazurek W: Efficacy of tilt training in patients with vasovagal syncope. Kardiol Pol 2006, 64:602-608.
26. Foglia-Manzillo G, Giada F, Gaggioli G, et al.: Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace 2004, 6:199-204.
27. Lu CC, Diedrich A, Tung CS, et al.: Water ingestion as prophylaxis against syncope. Circulation 2003, 108:2660-2665.
28. Barton J, Branch W: Approach to the patient with vertigo. UpToDate 2006. Available at http://www.uptodate.com. Accessed November 16, 2006.
29. • Labuguen RH. Initial evaluation of vertigo. Am Fam Physician 2006, 73:244-251. Article provides a detailed review for the approach to evaluating a patient with vertigo.
30. Baloh RW: Differentiating between peripheral and central causes of vertigo. Otolaryngol Head Neck Surg 1998, 119:55-59.
31. Hanley K, O'Dowd T: Symptoms of vertigo in general practice: a prospective study of diagnosis. Br J Gen Pract 2002, 52:809-812.
32. • Swartz R, Longwell P: Treatment of vertigo. Am Fam Physician 2005, 71:1115-1122. Article provides a detailed review of the treatment of vertigo.
33. Steenerson RL, Cronin GW, Marbach PM: Effectiveness of treatment techniques in 923 cases of benign paroxysmal positional vertigo. Laryngoscope 2005, 115:226-231.
34. Kroenke K, Lucas CA, Rosenberg ML, et al.: Causes of persistent dizziness: a prospective study of 100 patients in ambulatory care. Ann Intern Med 1992, 117:898-904.